Northwest Biotherapeutics (NWBO) EPS (Diluted) (2010 - 2026)

Northwest Biotherapeutics (NWBO) EPS (Diluted) (2010 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Diluted) (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 0.00
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 0.15
4 NuCana 279.75 Bn 279.75 Bn - -368,323.02
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 4.02
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 6.75
7 Belite Bio 62.51 Bn 62.51 Bn - 0.00
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 7.33
9 Revolution Medicines 37.78 Bn 37.78 Bn - -2.29
10 Northwest Biotherapeutics 253,653.43 -1.53 Mn - 0.00

Historic Data

Download Data
DateValue
Mar 31, 2026 0.00
Dec 31, 2025 0.00
Sep 30, 2025 -18.22
Jun 30, 2025 -11.08
Mar 31, 2025 -14.42
Dec 31, 2024 -22.94
Sep 30, 2024 -15.50
Jun 30, 2024 -15.08
Mar 31, 2024 -15.89
Dec 31, 2023 -12.79
Sep 30, 2023 -21.19
Jun 30, 2023 -13.50
Mar 31, 2023 -10.28
Dec 31, 2022 -27.86
Sep 30, 2022 -31.56
Jun 30, 2022 -29.55
Mar 31, 2022 -14.82
Dec 31, 2021 177.44
Sep 30, 2021 3.88
Jun 30, 2021 3.80